Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2003
11/06/2003US20030207426 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207425 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207424 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207423 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207422 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207421 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207420 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207419 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207418 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207417 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207416 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207415 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207414 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207403 For diagnosis or treatment of diseases with beta 10 polypeptides and alpha 2/ beta 10 heterodimers or their respective binding agents, such as thyroid gland disorders
11/06/2003US20030207399 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207397 For pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207396 For pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207395 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207390 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207389 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207388 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207387 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207386 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207385 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207384 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207383 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207382 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207381 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207380 For diagnosis and treatment of estrogenic disorder of mutant ER alpha
11/06/2003US20030207379 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207378 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207377 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207376 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207375 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207374 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207373 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207372 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207371 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207370 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207369 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207368 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207367 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207366 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207365 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207364 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207363 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207362 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207361 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207360 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207359 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207358 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207357 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207356 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207355 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207354 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207353 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207352 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207351 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207350 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207349 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207343 Method for determining the anticoagulatory potential of a sample
11/06/2003US20030207342 Without the separation of components of a sample; using cholesterol esterase and either cholesterol oxidase or cholesterol dehydrogenase, with phospholipase and measuring amount of hydrogen peroxide or reduced coenzyme formed
11/06/2003US20030207339 PCAM-1 marker protein, nucleic acid sequences encoding PCAM-1 and immunoassays for detection of PCAM-1
11/06/2003US20030207338 Wavy interface mixer
11/06/2003US20030207337 Olfactory receptors for isovaleric acid and related malodorants and use thereof in assays for identification of blockers of malodor
11/06/2003US20030207333 Feline pancreatic lipase composition and method of preparing and using such composition
11/06/2003US20030207332 For quantitative antigen analysis by determining change in enzymatic activity caused by immunological reaction
11/06/2003US20030207331 Encoding methods using up-converting phosphors for high-throughput screening of catalysts
11/06/2003US20030207330 Fibrinogen binding moieties
11/06/2003US20030207328 Analyte assay using particulate labels
11/06/2003US20030207327 Eukaryotic cells engineered to differ by as few as one encoded amino acid at a defined target locus; for therapeutic and pharmacogenic use
11/06/2003US20030207326 Methods and device for biomolecule characterization
11/06/2003US20030207325 Methods for identifying agents which alter histone protein acetylation, decrease aging, increase lifespan
11/06/2003US20030207318 Kinesin-like motor protein
11/06/2003US20030207316 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
11/06/2003US20030207311 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/06/2003US20030207309 Diagnostics and therapeutics for macular degeneration-related disorders
11/06/2003US20030207308 Capillary array and related methods
11/06/2003US20030207305 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds
11/06/2003US20030207304 Glycerol-doped aerogel coatings as biological capture media
11/06/2003US20030207299 Involves nucleic acid and amino acid sequences of human kinases; used in the diagnosis, treatment, and prevention of cancer, immune disorders, disorders affecting growth and development, cardiovascular diseases, and lipid disorders
11/06/2003US20030207297 Involves creating a database of genomic samples from healthy human donors; use of the database to identify and correlate with polymorphic genetic markers and other markers with diseases and conditions
11/06/2003US20030207293 Cryptic-like secreted protein
11/06/2003US20030207290 Methods, reagents, kits and apparatus for protein function analysis
11/06/2003US20030207285 Diagnostic and therapeutic methods useful for diagnosing, treating, preventing prognosing disorders related to the polypeptides
11/06/2003US20030207282 Method to amplify variable sequences without imposing primer sequences
11/06/2003US20030207274 Human NjmuR1-related gene variant associated with lung cancers
11/06/2003US20030207270 For creating, maintaining, improving and utilizing Herbal BioResponse Arrays (HBR Arrays); for standardization of herbal compositions
11/06/2003US20030207268 Methods for the diagnosis and prognosis of acute leukemias
11/06/2003US20030207267 Multiply-primed amplification of nucleic acid sequences
11/06/2003US20030207266 Thermal cycling protocol for nucleic acid amplification uses two primers with different thermal melting temperatures
11/06/2003US20030207264 Use of a single fluorophore rather than an "acceptor-donor" fluoresecence resonance energy transfer system offers synthesis and performance advantages; fluorogenic protease indicators
11/06/2003US20030207262 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
11/06/2003US20030207261 For use in kits
11/06/2003US20030207260 Contacted with probe that hybridizes one complementary sequence
11/06/2003US20030207258 Biomolecule diagnostic devices and method for producing biomolecule diagnostic devices
11/06/2003US20030207257 Based on pattern of active and deactivated areas of receptive material
11/06/2003US20030207256 Biomolecule diagnostic devices and method for producing biomolecule diagnostic devices
11/06/2003US20030207255 Based on pattern of active and deactivated areas of receptive material
11/06/2003US20030207254 Based on pattern of active and deactivated areas of receptive material